ZOC2017217

· Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZOC2017217, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Pilot Study to Evaluate the Efficacy and Safety of ZOC2017217 in Subjects With Age-Related Cataract [Phase 2]

See pricing